112 related articles for article (PubMed ID: 37216488)
21. Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in Sweden.
Ljung R; Martin L; Lagergren J
Eur J Cancer; 2011 Sep; 47(14):2128-32. PubMed ID: 21489778
[TBL] [Abstract][Full Text] [Related]
22. Airborne occupational exposures and risk of oesophageal and cardia adenocarcinoma.
Jansson C; Plato N; Johansson AL; Nyrén O; Lagergren J
Occup Environ Med; 2006 Feb; 63(2):107-12. PubMed ID: 16421388
[TBL] [Abstract][Full Text] [Related]
23. Annual surgeon and hospital volume of gastrectomy and gastric adenocarcinoma survival in a population-based cohort study.
Asplund J; Mattsson F; Plecka-Östlund M; Markar SR; Lagergren J
Acta Oncol; 2022 Apr; 61(4):425-432. PubMed ID: 35023804
[TBL] [Abstract][Full Text] [Related]
24. Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer.
Koppert LB; Lemmens VE; Coebergh JW; Steyerberg EW; Wijnhoven BP; Tilanus HW; Janssen-Heijnen ML
Br J Surg; 2012 Dec; 99(12):1693-700. PubMed ID: 23132417
[TBL] [Abstract][Full Text] [Related]
25. Survival Trends in Gastric Adenocarcinoma: A Population-Based Study in Sweden.
Asplund J; Kauppila JH; Mattsson F; Lagergren J
Ann Surg Oncol; 2018 Sep; 25(9):2693-2702. PubMed ID: 29987609
[TBL] [Abstract][Full Text] [Related]
26. Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer.
Ross AE; Feng Z; Pierorazio PM; Landis P; Walsh PC; Carter HB; Trock BJ; Schaeffer EM
BJU Int; 2012 Sep; 110(5):651-7. PubMed ID: 22289613
[TBL] [Abstract][Full Text] [Related]
27. Weekday of oesophageal cancer surgery in relation to early postoperative outcomes in a nationwide Swedish cohort study.
Lagergren J; Mattsson F; Lagergren P
BMJ Open; 2016 May; 6(5):e011097. PubMed ID: 27246001
[TBL] [Abstract][Full Text] [Related]
28. University hospital status and prognosis following surgery for esophageal cancer.
Markar SR; Wahlin K; Lagergren P; Lagergren J
Eur J Surg Oncol; 2016 Aug; 42(8):1191-5. PubMed ID: 27288216
[TBL] [Abstract][Full Text] [Related]
29. Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.
Herbst RS; Arkenau HT; Santana-Davila R; Calvo E; Paz-Ares L; Cassier PA; Bendell J; Penel N; Krebs MG; Martin-Liberal J; Isambert N; Soriano A; Wermke M; Cultrera J; Gao L; Widau RC; Mi G; Jin J; Ferry D; Fuchs CS; Petrylak DP; Chau I
Lancet Oncol; 2019 Aug; 20(8):1109-1123. PubMed ID: 31301962
[TBL] [Abstract][Full Text] [Related]
30. Marital status, education, and income in relation to the risk of esophageal and gastric cancer by histological type and site.
Lagergren J; Andersson G; Talbäck M; Drefahl S; Bihagen E; Härkönen J; Feychting M; Ljung R
Cancer; 2016 Jan; 122(2):207-12. PubMed ID: 26447737
[TBL] [Abstract][Full Text] [Related]
31. Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma.
Moore JL; Subesinghe M; Santaolalla A; Green M; Deere H; Van Hemelrijck M; Lagergren J; Chicklore S; Maisey N; Gossage JA; Kelly M; Baker CR; Davies AR;
Eur Radiol; 2023 May; 33(5):3647-3659. PubMed ID: 36920518
[TBL] [Abstract][Full Text] [Related]
32. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
Brusselaers N; Wahlin K; Engstrand L; Lagergren J
BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
[TBL] [Abstract][Full Text] [Related]
33. Risk of adenocarcinomas of the oesophagus and gastric cardia in patients hospitalized for asthma.
Ye W; Chow WH; Lagergren J; Boffetta P; Boman G; Adami HO; Nyrén O
Br J Cancer; 2001 Nov; 85(9):1317-21. PubMed ID: 11720467
[TBL] [Abstract][Full Text] [Related]
34. 5α-reductase inhibitors impact prognosis of urothelial carcinoma.
Wang CS; Li CC; Juan YS; Wu WJ; Lee HY
BMC Cancer; 2020 Sep; 20(1):872. PubMed ID: 32917158
[TBL] [Abstract][Full Text] [Related]
35. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia.
Lagergren J; Bergström R; Lindgren A; Nyrén O
Int J Cancer; 2000 Feb; 85(3):340-6. PubMed ID: 10652424
[TBL] [Abstract][Full Text] [Related]
36. Time shift in early postoperative mortality after oesophagectomy for cancer.
Rutegård M; Lagergren P; Johar A; Lagergren J
Ann Surg Oncol; 2015 Sep; 22(9):3144-9. PubMed ID: 25649859
[TBL] [Abstract][Full Text] [Related]
37. Surgery in oesophago-gastric cancer with metastatic disease: Treatment, prognosis and preoperative patient selection.
Schmidt T; Alldinger I; Blank S; Klose J; Springfeld C; Dreikhausen L; Weichert W; Grenacher L; Bruckner T; Lordick F; Ulrich A; Büchler MW; Ott K
Eur J Surg Oncol; 2015 Oct; 41(10):1340-7. PubMed ID: 26213358
[TBL] [Abstract][Full Text] [Related]
38. The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials.
Chau I; Norman AR; Cunningham D; Oates J; Hawkins R; Iveson T; Nicolson M; Harper P; Seymour M; Hickish T
Ann Oncol; 2009 May; 20(5):885-91. PubMed ID: 19164454
[TBL] [Abstract][Full Text] [Related]
39. Motor vehicle exposure and risk of oesophageal adenocarcinoma.
Lagergren J; Jansson C; Lu Y
Eur J Cancer; 2011 Jul; 47(10):1446-9. PubMed ID: 21570825
[TBL] [Abstract][Full Text] [Related]
40. Menopausal hormone therapy and the risk of esophageal and gastric cancer.
Brusselaers N; Maret-Ouda J; Konings P; El-Serag HB; Lagergren J
Int J Cancer; 2017 Apr; 140(7):1693-1699. PubMed ID: 28006838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
